TRIUMEQ- dolutegravir sodium, abacavir sulfate, lamivudine tablet, film coated
Glaxo Operations UK Ltd
----------
PRINICPAL DISPLAY PANEL
NDC 49702-231-13
Triumeq
(abacavir, dolutegravir, and lamivudine)
600 mg/50 mg/300 mg
TABLETS
Each film-coated tablet contains abacavir sulfate equivalent to 600 mg of abacavir, dolutegravir sodium equivalent to 50 mg of dolutegravir, and 300 mg of lamivudine.
Store in original package at controlled room temperature of 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) (See USP). Keep bottle tightly closed; protect from moisture. Do not remove desiccant.
Do not use if printed safety seal under cap is broken or missing.
See prescribing information for dosage information.
Notice to Authorized Dispenser:
Each time TRIUMEQ is dispensed, give the patient a Medication Guide and Warning Card from the carton.
Rx only
30 Tablets
TRIUMEQ
dolutegravir sodium, abacavir sulfate, lamivudine tablet, film coated |
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
Labeler - Glaxo Operations UK Ltd (424738227) |